EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem

Antibodies are one of the most important groups of biomolecules for both clinical and basic research and have been developed as potential therapeutics. Affinity is the key feature for biological activity and clinical efficacy of an antibody, especially of therapeutic antibodies, and thus antibody af...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hai-nan Zhang, Jun-biao Xue, Aru Ze-ling Wang, He-wei Jiang, Siva Bhararth Merugu, Da-wei Li, Sheng-ce Tao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/9733a6ddde754c66b8518f3ccfab7729
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9733a6ddde754c66b8518f3ccfab7729
record_format dspace
spelling oai:doaj.org-article:9733a6ddde754c66b8518f3ccfab77292021-12-03T05:07:49ZEASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem1664-322410.3389/fimmu.2021.747267https://doaj.org/article/9733a6ddde754c66b8518f3ccfab77292021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.747267/fullhttps://doaj.org/toc/1664-3224Antibodies are one of the most important groups of biomolecules for both clinical and basic research and have been developed as potential therapeutics. Affinity is the key feature for biological activity and clinical efficacy of an antibody, especially of therapeutic antibodies, and thus antibody affinity improvement is indispensable and still remains challenging. To address this issue, we developed the E. coliAssisted Speed affINity-maturation Evolution SyStem (EASINESS) for continuous directed evolution of Ag–Ab interactions. Two key components of EASINESS include a mutation system modified from error-prone DNA polymerase I (Pol I) that selectively mutates ColE1 plasmids in E. coli and a protein–protein interaction selection system from mDHFR split fragments. We designed a GCN4 variant which barely forms a homodimer, and during a single round of evolution, we reversed the homodimer formation activity from the GCN4 variant to verify the feasibility of EASINESS. We then selected a potential therapeutic antibody 18A4Hu and improved the affinity of the antibody (18A4Hu) to its target (ARG2) 12-fold in 7 days while requiring very limited hands-on time. Remarkably, these variants of 18A4Hu revealed a significant improved ability to inhibit melanoma pulmonary metastasis in a mouse model. These results indicate EASINESS could be as an attractive choice for antibody affinity maturation.Hai-nan ZhangJun-biao XueAru Ze-ling WangHe-wei JiangSiva Bhararth MeruguDa-wei LiSheng-ce TaoFrontiers Media S.A.articleantibody affinity improvementdirected evolution18A4Huerror-prone DNA polymerase Iprotein-fragment complementation assayImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic antibody affinity improvement
directed evolution
18A4Hu
error-prone DNA polymerase I
protein-fragment complementation assay
Immunologic diseases. Allergy
RC581-607
spellingShingle antibody affinity improvement
directed evolution
18A4Hu
error-prone DNA polymerase I
protein-fragment complementation assay
Immunologic diseases. Allergy
RC581-607
Hai-nan Zhang
Jun-biao Xue
Aru Ze-ling Wang
He-wei Jiang
Siva Bhararth Merugu
Da-wei Li
Sheng-ce Tao
EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem
description Antibodies are one of the most important groups of biomolecules for both clinical and basic research and have been developed as potential therapeutics. Affinity is the key feature for biological activity and clinical efficacy of an antibody, especially of therapeutic antibodies, and thus antibody affinity improvement is indispensable and still remains challenging. To address this issue, we developed the E. coliAssisted Speed affINity-maturation Evolution SyStem (EASINESS) for continuous directed evolution of Ag–Ab interactions. Two key components of EASINESS include a mutation system modified from error-prone DNA polymerase I (Pol I) that selectively mutates ColE1 plasmids in E. coli and a protein–protein interaction selection system from mDHFR split fragments. We designed a GCN4 variant which barely forms a homodimer, and during a single round of evolution, we reversed the homodimer formation activity from the GCN4 variant to verify the feasibility of EASINESS. We then selected a potential therapeutic antibody 18A4Hu and improved the affinity of the antibody (18A4Hu) to its target (ARG2) 12-fold in 7 days while requiring very limited hands-on time. Remarkably, these variants of 18A4Hu revealed a significant improved ability to inhibit melanoma pulmonary metastasis in a mouse model. These results indicate EASINESS could be as an attractive choice for antibody affinity maturation.
format article
author Hai-nan Zhang
Jun-biao Xue
Aru Ze-ling Wang
He-wei Jiang
Siva Bhararth Merugu
Da-wei Li
Sheng-ce Tao
author_facet Hai-nan Zhang
Jun-biao Xue
Aru Ze-ling Wang
He-wei Jiang
Siva Bhararth Merugu
Da-wei Li
Sheng-ce Tao
author_sort Hai-nan Zhang
title EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem
title_short EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem
title_full EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem
title_fullStr EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem
title_full_unstemmed EASINESS: E. coli Assisted Speedy affINity-maturation Evolution SyStem
title_sort easiness: e. coli assisted speedy affinity-maturation evolution system
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/9733a6ddde754c66b8518f3ccfab7729
work_keys_str_mv AT hainanzhang easinessecoliassistedspeedyaffinitymaturationevolutionsystem
AT junbiaoxue easinessecoliassistedspeedyaffinitymaturationevolutionsystem
AT aruzelingwang easinessecoliassistedspeedyaffinitymaturationevolutionsystem
AT heweijiang easinessecoliassistedspeedyaffinitymaturationevolutionsystem
AT sivabhararthmerugu easinessecoliassistedspeedyaffinitymaturationevolutionsystem
AT daweili easinessecoliassistedspeedyaffinitymaturationevolutionsystem
AT shengcetao easinessecoliassistedspeedyaffinitymaturationevolutionsystem
_version_ 1718373946026360832